Market cap
$0 Mln
Revenue (TTM)
$1 Mln
P/E Ratio
--
P/B Ratio
11.2
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | 50.00 | -- | 213.95 | 1.75 | 4.40 |
| EBIT | -31.27 | 12.65 | 34.31 | 3.49 | -1.32 |
| Net Profit | -30.99 | 12.03 | 10.78 | -7.71 | -12.04 |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | TTM | Dec-23 | Dec-22 |
| EBIT-Margin
| -9,689.11 | -6,278.03 | -1,153.83 | -24,028.33 | -3,076.44 |
| Net Margin
| -- | -1,807.79 | -1,568.15 | -- | -- |
| Return on equity
| -575.75 | -741.68 | -- | -1,508.09 | -132.83 |
| Return on Capital
| -181.20 | -181.41 | -- | -371.98 | -103.40 |
| Return on Assets
| -133.14 | -110.42 | -133.87 | -241.08 | -95.20 |
| Debt to Equity (x)
| -- | -- | 0.00 | -1.29 | 0.60 |
Profitability
ROCE
--
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
-371.98
|
-103.40
|
-68.22
|
-153.61
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
--
--
Profit after tax / Average Net worth * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
-1,508.09
|
-132.83
|
-86.32
|
-374.74
|
|
Peer Median
|
-40.29
|
--
|
--
|
--
|
--
|
ROA
-133.87
Lower than Peers by 103.03
Profit after tax / Average Total assets * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-133.87
|
-241.08
|
-95.20
|
-63.15
|
-65.34
|
|
Peer Median
|
-30.84
|
--
|
--
|
--
|
--
|
EBIT Margin
-1,153.83
Lower than Peers by 1,071.62
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-1,153.83
|
-24,028.33
|
-3,076.44
|
-1,962.54
|
-1,256.32
|
|
Peer Median
|
-82.21
|
--
|
--
|
--
|
--
|
Net Margin
-1,568.15
Lower than Peers by 1,478.27
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-1,568.15
|
-24,091.67
|
-3,014.67
|
-1,796.58
|
-3,955.81
|
|
Peer Median
|
-89.88
|
--
|
--
|
--
|
--
|
Cash Profit Margin
-0.01
Lower than Peers by 0.01
(Net profit + Depreciation) / Gross Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-0.01
|
--
|
--
|
--
|
--
|
|
Peer Median
|
0.00
|
--
|
--
|
--
|
--
|
Revenue Growth
213.95
Higher than Peers by 159.92
Year on year growth in net sales
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
213.95
|
-0.87
|
-0.27
|
-0.23
|
-0.01
|
|
Peer Median
|
54.03
|
--
|
--
|
--
|
--
|
EBIT Growth
34.31
Higher than Peers by 35.26
Year on year growth in operating profit (EBIT)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
34.31
|
-4.14
|
-14.89
|
-20.04
|
-16.78
|
|
Peer Median
|
-0.95
|
--
|
--
|
--
|
--
|
Net Profit Growth
10.78
Higher than Peers by 17.97
Year on year growth in profit after tax
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
10.78
|
-6.55
|
-22.98
|
-8.08
|
21.23
|
|
Peer Median
|
-7.19
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
--
--
Total debt / Net worth
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
-1.29
|
0.60
|
0.20
|
0.38
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
-0.27
--
(Short term borrowings / Net worth)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-0.27
|
-0.55
|
0.28
|
0.07
|
0.12
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
0.16
Lower than Peers by 5.65
Current Assets / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
0.16
|
0.29
|
3.12
|
9.59
|
5.70
|
|
Peer Median
|
5.80
|
--
|
--
|
--
|
--
|
Quick Ratio
0.16
Lower than Peers by 5.54
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
0.16
|
--
|
3.12
|
--
|
--
|
|
Peer Median
|
5.69
|
--
|
--
|
--
|
--
|
Interest Coverage
-704.67
Lower than Peers by 702.58
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-704.67
|
--
|
-337.66
|
-8.63
|
-8.62
|
|
Peer Median
|
-2.09
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
--
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
--
|
6.67
|
32.25
|
14.14
|
|
Peer Median
|
18.97
|
--
|
--
|
--
|
--
|
Asset Turnover
0.09
Higher than Peers by 0.02
Sales / Average Total Assets
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
0.09
|
0.01
|
0.03
|
0.04
|
0.05
|
|
Peer Median
|
0.07
|
--
|
--
|
--
|
--
|
Receivable days
--
--
Average Debtors / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
182.63
|
92.53
|
92.50
|
46.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
--
--
Average Inventory / Sales * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
0.00
|
0.00
|
--
|
0.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
--
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
825.59
|
53.45
|
45.18
|
11.86
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
--
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
-642.96
|
39.08
|
--
|
35.00
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Book Value
11.23
Higher than Peers by 5.88
Current share price divided by book value per share in the latest financial year
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
11.23
|
--
|
--
|
--
|
--
|
|
Peer Median
|
5.35
|
--
|
--
|
--
|
--
|
Dividend Yield
--
--
Dividend per share in the past twelve months divided by current share price
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
-0.49
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
-0.49
|
-0.15
|
0.13
|
1.12
|
0.65
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Market Cap
0
Lower than Peers by 147
Current Share price multiplied by latest total number of shares outstanding
|
Company Name
|
TTM
|
Dec-23
|
Dec-22
|
Dec-21
|
Dec-20
|
|---|---|---|---|---|---|
|
Yield10 Bioscience (YTEN)
|
0
|
--
|
--
|
--
|
--
|
|
Peer Median
|
147
|
--
|
--
|
--
|
--
|